• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮性卵巢癌中的肿瘤异质性与组织病理学

Tumor heterogeneity and histopathology in epithelial ovarian cancer.

作者信息

Hernandez E, Rosenshein N B, Bhagavan B S, Parmley T H

出版信息

Obstet Gynecol. 1984 Mar;63(3):330-4.

PMID:6700855
Abstract

The histopathology of the original and the persistent or recurrent epithelial ovarian cancer in 34 patients was simultaneously reviewed by two pathologists. The time between removal of the primary tumor and removal of the persistent or recurrent tumor ranged from four to 132 months (median, 13 months; mean, 25 months). The initial operation was followed by multiagent chemotherapy in 23 patients, single-agent chemotherapy in seven, radiation and chemotherapy in two, radiation in one, and no therapy in one patient. In four of the 34 primary tumors, a mixed tumor composition was initially identified. In comparing the initial histopathology with that of persistent or recurrent tumors, a change was identified in nine patients. In four patients, the tumor changed from a mixed to an undifferentiated histologic type; in four patients there was a change from a lower to a higher tumor grade, and two of these patients also had a change in tumor cell type from serous to undifferentiated. In the ninth patient, the tumor changed from a large cell undifferentiated to a small cell undifferentiated carcinoma. The observed changes could be the result of 1) modification of the tumor by cytotoxic therapy, 2) spontaneous dedifferentiation of the initial tumor, 3) tumor cell heterogeneity with preferential growth of one cell type over the others, or 4) the development of a second primary tumor.

摘要

两位病理学家同时回顾了34例原发性及持续性或复发性上皮性卵巢癌的组织病理学情况。原发性肿瘤切除与持续性或复发性肿瘤切除之间的时间间隔为4至132个月(中位数为13个月;平均数为25个月)。23例患者在初次手术后接受了多药化疗,7例接受了单药化疗,2例接受了放疗及化疗,1例接受了放疗,1例未接受任何治疗。在34例原发性肿瘤中,有4例最初被确定为混合性肿瘤成分。在比较原发性肿瘤与持续性或复发性肿瘤的组织病理学情况时,发现9例患者有变化。4例患者的肿瘤从混合性组织学类型转变为未分化型;4例患者的肿瘤分级从低级别变为高级别,其中2例患者的肿瘤细胞类型也从浆液性转变为未分化型。在第9例患者中,肿瘤从大细胞未分化癌转变为小细胞未分化癌。观察到的这些变化可能是以下原因导致的:1)细胞毒性疗法对肿瘤的改变;2)初始肿瘤的自发去分化;3)肿瘤细胞异质性,其中一种细胞类型比其他细胞类型优先生长;4)第二原发性肿瘤的发生。

相似文献

1
Tumor heterogeneity and histopathology in epithelial ovarian cancer.上皮性卵巢癌中的肿瘤异质性与组织病理学
Obstet Gynecol. 1984 Mar;63(3):330-4.
2
The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.伴有非侵袭性种植的卵巢浆液性交界性肿瘤的复发率和总生存率与时间相关。
Am J Surg Pathol. 2006 Nov;30(11):1367-71. doi: 10.1097/01.pas.0000213294.81154.95.
3
Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging.全面手术分期后高危Ⅰ期上皮性卵巢癌的铂类化疗
Obstet Gynecol. 1993 Jul;82(1):143-7.
4
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.肿瘤细胞类型能够被重复性诊断,并且在接受最大程度肿瘤细胞减灭术的卵巢癌患者中具有独立的预后意义。
Hum Pathol. 2008 Aug;39(8):1239-51. doi: 10.1016/j.humpath.2008.01.003. Epub 2008 Jul 7.
5
Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.I期卵巢癌全面手术分期后的二次剖腹探查术。
Obstet Gynecol. 1993 Jul;82(1):139-42.
6
Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.卵巢非小细胞神经内分泌癌:11例临床病理及免疫组化研究
Am J Surg Pathol. 2007 May;31(5):774-82. doi: 10.1097/01.pas.0000213422.53750.d1.
7
Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.美法仑与顺铂联合化疗作为晚期卵巢癌初始治疗的随机试验:初步及长期结果——东部肿瘤协作组E2878研究
Cancer. 1996 Feb 15;77(4):733-42.
8
Ovarian mucinous cystadenocarcinoma with sarcoma-appearing mural nodule of anaplastic carcinoma.卵巢黏液性囊腺癌伴间变性癌的肉瘤样壁结节。
Gynecol Oncol. 1993 Aug;50(2):259-63. doi: 10.1006/gyno.1993.1204.
9
Ovarian serous borderline tumors with invasive peritoneal implants.伴有侵袭性腹膜种植的卵巢浆液性交界性肿瘤
Cancer. 1998 Mar 15;82(6):1096-103.
10
The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.全面手术分期在早期上皮性卵巢癌治疗中的益处。
Gynecol Oncol. 2002 May;85(2):351-5. doi: 10.1006/gyno.2002.6636.

引用本文的文献

1
18F-fluorodeoxyglucose positron emission tomography in patients with recurrent ovarian cancer: in comparison with vascularity, Ki-67, p53, and histologic grade.18F-氟脱氧葡萄糖正电子发射断层扫描在复发性卵巢癌患者中的应用:与血管生成、Ki-67、p53及组织学分级的比较
Eur Radiol. 2007 Feb;17(2):409-17. doi: 10.1007/s00330-006-0326-y. Epub 2006 Jun 20.
2
Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.人类卵巢及其肿瘤中的肿瘤标志物。一项比较性免疫组织化学研究。
Am J Pathol. 1987 Feb;126(2):230-42.